BOSIA, Amalia
BOSIA, Amalia
Dip. GENETICA, BIOLOGIA E BIOCHIMICA (attivo dal 01/01/1900 al 31/12/2012)
4-Methyl-3-(arylsulfonyl)furoxans: a new class of potent inhibitors of platelet aggregation.
1992-01-01 CALVINO R ;FRUTTERO R ;GHIGO D ;BOSIA A ;PESCARMONA GP ;GASCO A
[Changes in erythrocyte deformability following changes in oxido-reductive metabolism in diabetes mellitus]
1983-01-01 GHIGO D ;BOSIA A ;PAGANI A ;PESCARMONA GP ;PAGANO G ;LENTI G
[The molecular basis for increased rigidity of the erythrocyte membrane]
1983-01-01 PESCARMONA GP ;GHIGO D ;BOSIA A
A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells
2011-01-01 Kopecka J; Campia I; Olivero P; Pescarmona GP; Ghigo D; Bosia A; Riganti C
A simplified method for the pentose phosphate pathway assay in red cells.
1982-01-01 PESCARMONA GP ;BOSIA A ;ARESE P ;SARTORI ML ;GHIGO D
Absence of soluble CD14 in saliva of young patients with dental caries
2007-01-01 BERGANDI L; DEFABIANIS P; RE F; PRETI G; ALDIERI E; GARETTO S; BOSIA A; GHIGO D
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells
2011-01-01 M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia
Activation of endothelial guanylate cyclase inhibits cellular reactivity.
1995-01-01 HELLER R ;BUSSOLINO F ;GHIGO D ;PESCARMONA GP ;CALVINO R ;GASCO A ;TILL U ;BOSIA A
Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells
2008-01-01 Riganti C; Doublier S; Costamagna C; Aldieri E; Pescarmona G; Ghigo D; Bosia A
Altered nitric oxide/cGMP platelet signaling pathway in platelets from patients with acute coronary syndromes
2010-01-01 Bergandi L; Cordero M; Anselmino M; Ferraro G; Ravera L; Dalmasso P; Moiraghi C; Trevi GP; Ghigo D; Bosia A; Bergerone S
Altered nitric oxide/cGMP platelet signalling pathway in platelets from patients with acute coronary syndromes
2009-01-01 M. Anselmino; L. Bergandi; P. Dalmasso; M. Cordero; C. Moiraghi; L. Ravera; D. Ghigo; G.P. Trevi; A. Bosia; S. Bergerone.
Antioxidants prevent the RhoA inhibition evoked by crocidolite asbestos in human mesothelial and mesothelioma cells
2011-01-01 E. Gazzano; E. Aldieri; C. Riganti; F. Silvagno; S. Orecchia; P.G. Betta; S. Doublier; M. Polimeni; A. Bosia; D. Ghigo
Antioxidants Prevent the RhoA Inhibition Evoked by Crocidolite Asbestos in Human Mesothelial and Mesothelioma Cells.
2011-01-01 Aldieri E; Riganti C; Silvagno F; Orecchia S; Betta PG; Doublier S; Gazzano E; Polimeni M; Bosia A; Ghigo D.
Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1α and P-glycoprotein overexpression
2009-01-01 Riganti C; Doublier S; Viarisio D; Miraglia E; Pescarmona G; Ghigo D; Bosia A
Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF-kB activation
2003-01-01 ALDIERI E.; ATRAGENE D.; BERGANDI L.; RIGANTI C.; COSTAMAGNA C.; A. BOSIA; GHIGO D.
Asbestos induces doxorubicin resistance in MM98 mesothelioma cells via HIF-1alpha
2008-01-01 Riganti C; Doublier S; Aldieri E; Orecchia S; Betta PG; Gazzano E; Ghigo D; Bosia A
Asbestos induces nitric oxide synthesis in mesothelioma cells via Rho signaling inhibition
2007-01-01 RIGANTI C; ORECCHIA S; SILVAGNO F; PESCARMONA GP; BETTA PG; GAZZANO E; ALDIERI E; GHIGO D; BOSIA A
Atorvastatin modulates anti-proliferative and pro-proliferative signals in Her2/neu-positive mammary cancer.
2011-01-01 Riganti C; Pinto H; Bolli E; Belisario DC; Calogero RA; Bosia A; Cavallo F
Cardiac glycosides as new modulators of cholesterol metabolism
2012-01-01 I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti
Cardiac glycosides modulate cholesterol metabolism via SREBP-2 and LXR activation
2013-01-01 I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 4-Methyl-3-(arylsulfonyl)furoxans: a new class of potent inhibitors of platelet aggregation. | 1992 | CALVINO R ;FRUTTERO R ;GHIGO D ;BOSIA A ;PESCARMONA GP ;GASCO A | |
| [Changes in erythrocyte deformability following changes in oxido-reductive metabolism in diabetes mellitus] | 1983 | GHIGO D ;BOSIA A ;PAGANI A ;PESCARMONA GP ;PAGANO G ;LENTI G | |
| [The molecular basis for increased rigidity of the erythrocyte membrane] | 1983 | PESCARMONA GP ;GHIGO D ;BOSIA A | |
| A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells | 2011 | Kopecka J; Campia I; Olivero P; Pescarmona GP; Ghigo D; Bosia A; Riganti C | |
| A simplified method for the pentose phosphate pathway assay in red cells. | 1982 | PESCARMONA GP ;BOSIA A ;ARESE P ;SARTORI ML ;GHIGO D | |
| Absence of soluble CD14 in saliva of young patients with dental caries | 2007 | BERGANDI L; DEFABIANIS P; RE F; PRETI G; ALDIERI E; GARETTO S; BOSIA A; GHIGO D | |
| Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells | 2011 | M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia | |
| Activation of endothelial guanylate cyclase inhibits cellular reactivity. | 1995 | HELLER R ;BUSSOLINO F ;GHIGO D ;PESCARMONA GP ;CALVINO R ;GASCO A ;TILL U ;BOSIA A | |
| Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells | 2008 | Riganti C; Doublier S; Costamagna C; Aldieri E; Pescarmona G; Ghigo D; Bosia A | |
| Altered nitric oxide/cGMP platelet signaling pathway in platelets from patients with acute coronary syndromes | 2010 | Bergandi L; Cordero M; Anselmino M; Ferraro G; Ravera L; Dalmasso P; Moiraghi C; Trevi GP; Ghigo D; Bosia A; Bergerone S | |
| Altered nitric oxide/cGMP platelet signalling pathway in platelets from patients with acute coronary syndromes | 2009 | M. Anselmino; L. Bergandi; P. Dalmasso; M. Cordero; C. Moiraghi; L. Ravera; D. Ghigo; G.P. Trevi; A. Bosia; S. Bergerone. | |
| Antioxidants prevent the RhoA inhibition evoked by crocidolite asbestos in human mesothelial and mesothelioma cells | 2011 | E. Gazzano; E. Aldieri; C. Riganti; F. Silvagno; S. Orecchia; P.G. Betta; S. Doublier; M. Polimeni; A. Bosia; D. Ghigo | |
| Antioxidants Prevent the RhoA Inhibition Evoked by Crocidolite Asbestos in Human Mesothelial and Mesothelioma Cells. | 2011 | Aldieri E; Riganti C; Silvagno F; Orecchia S; Betta PG; Doublier S; Gazzano E; Polimeni M; Bosia A; Ghigo D. | |
| Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1α and P-glycoprotein overexpression | 2009 | Riganti C; Doublier S; Viarisio D; Miraglia E; Pescarmona G; Ghigo D; Bosia A | |
| Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF-kB activation | 2003 | ALDIERI E.; ATRAGENE D.; BERGANDI L.; RIGANTI C.; COSTAMAGNA C.; A. BOSIA; GHIGO D. | |
| Asbestos induces doxorubicin resistance in MM98 mesothelioma cells via HIF-1alpha | 2008 | Riganti C; Doublier S; Aldieri E; Orecchia S; Betta PG; Gazzano E; Ghigo D; Bosia A | |
| Asbestos induces nitric oxide synthesis in mesothelioma cells via Rho signaling inhibition | 2007 | RIGANTI C; ORECCHIA S; SILVAGNO F; PESCARMONA GP; BETTA PG; GAZZANO E; ALDIERI E; GHIGO D; BOSIA A | |
| Atorvastatin modulates anti-proliferative and pro-proliferative signals in Her2/neu-positive mammary cancer. | 2011 | Riganti C; Pinto H; Bolli E; Belisario DC; Calogero RA; Bosia A; Cavallo F | |
| Cardiac glycosides as new modulators of cholesterol metabolism | 2012 | I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti | |
| Cardiac glycosides modulate cholesterol metabolism via SREBP-2 and LXR activation | 2013 | I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti |